Literature DB >> 19941253

Detection and characterization of endoleaks following endovascular treatment of abdominal aortic aneurysms using contrast harmonic imaging (CHI) with quantitative perfusion analysis (TIC) compared to CT angiography (CTA).

E M Jung1, J Rennert, C Fellner, W Uller, W Jung, A Schreyer, P Heiss, P Hoffstetter, S Feuerbach, P Kasparzk, N Zorger, K Pfister.   

Abstract

PURPOSE: To show the feasibility of the detection of endoleaks following endovascular treatment of aortic aneurysms using contrast harmonic imaging (CHI) in comparison to computed tomography angiography (CTA).
MATERIALS AND METHODS: 51 patients with suspected endoleaks, who underwent previous endovascular treatment for abdominal aortic aneurysm, were examined using CTA and vascular ultrasound. Biphasic CTA in all cases and digital subtraction angiography (DSA) in 8 patients were evaluated by two radiologists in consensus and served as the standard of reference. Ultrasound was performed by an experienced examiner with a multi-frequency linear transducer (2 - 4 MHz) using CHI following bolus injection of 2.4 ml of SonoVue® IV (maximum 5 ml). All images were evaluated by two observers in consensus regarding the reperfusion of the abdominal aneurysm using time intensity curve (TIC) analysis.
RESULTS: In 30 of 51 patients, endoleaks were detected concordantly in CHI and CTA. In 20 of 51 patients, no endoleak was found in CHI and CTA/DSA. In one patient, a type II endoleak could initially only be detected in CHI and was later confirmed in follow-up examinations by CTA (sens. 99%, spec. 93%, NPV 99 %, PPV 95%). TIC analysis allowed evaluation of the perfusion dynamics of endoleaks in all patients. Significant differences were found (p < 0.05, Mann Whitney U Test) regarding the perfusion within the aneurysm when an endoleak was present (10.39 ± 4.29 dB) or not present (6.42 ± 2.86 dB).
CONCLUSION: CHI with perfusion analysis allows definite detection of endoleaks, especially if contraindications for CTA are present. CHI presents an alternative for follow-up monitoring. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941253     DOI: 10.1055/s-0028-1109811

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  7 in total

Review 1.  Evolving clinical applications of contrast-enhanced ultrasound (CEUS) in the abdominal aorta.

Authors:  Vasileios Rafailidis; Sasan Partovi; Alexander Dikkes; Dean A Nakamoto; Nami Azar; Daniel Staub
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

Review 2.  Multimodality imaging assessment of endoleaks post-endovascular aortic repair.

Authors:  Sasan Partovi; Thomas Trischman; Vasileios Rafailidis; Suvranu Ganguli; Fabian Rengier; Harold Goerne; Prabhakar Rajiah; Daniel Staub; Indravadan J Patel; George Oliveira; Brian Ghoshhajra
Journal:  Br J Radiol       Date:  2018-05-02       Impact factor: 3.039

Review 3.  Contrast-enhanced ultrasound: clinical applications in patients with atherosclerosis.

Authors:  Arend F L Schinkel; Mathias Kaspar; Daniel Staub
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-24       Impact factor: 2.357

Review 4.  Contemporary Applications of Ultrasound in Abdominal Aortic Aneurysm Management.

Authors:  Mark Scaife; Triantafillos Giannakopoulos; Georges E Al-Khoury; Rabih A Chaer; Efthymios D Avgerinos
Journal:  Front Surg       Date:  2016-05-27

Review 5.  Ultrasound elastography.

Authors:  Xin-Wu Cui; Kang-Ning Li; Ai-Jiao Yi; Bin Wang; Qi Wei; Ge-Ge Wu; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2022-05-02       Impact factor: 5.275

Review 6.  Contrast-enhanced ultrasound (CEUS) of the abdominal vasculature.

Authors:  Vasileios Rafailidis; Cheng Fang; Gibran T Yusuf; Dean Y Huang; Paul S Sidhu
Journal:  Abdom Radiol (NY)       Date:  2018-04

7.  General principles and overview of vascular contrast-enhanced ultrasonography.

Authors:  Vasileios Rafailidis; Dean Y Huang; Gibran Timothy Yusuf; Paul S Sidhu
Journal:  Ultrasonography       Date:  2019-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.